Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹357.10
Market cap
₹2,187 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.37 Cr
P/E (TTM)
-307.2×Sector 47.4×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:28 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.

Value
₹9.82 Cr
09:49 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec's subsidiary received a GST Show Cause Notice. The notice alleges a total tax liability of ₹4.06 Crore for FY 2022-23.

Value
₹4.06 Cr
15:21 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec filed a High Court appeal against an industrial tribunal award involving 23 workmen. The court granted interim relief, preventing coercive steps against the company.

20:36 IST NSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec filed appeals against three tribunal awards and will challenge a fourth. The company believes the awards are challengeable and foresees no material financial impact.

11:11 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec Ltd won a favorable order from the ITAT, Delhi, resulting in the cancellation of a ₹9.16 Crore tax demand for AY 2020-21. The tribunal set aside the previous disallowance of ₹3.44 Crore in expenses, marking a positive financial outcome for the company regarding its ongoing tax litigation.

Value
₹9.16 Cr
16:15 IST NSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec Limited received four tribunal awards regarding labor disputes dating back to 2014. The Tribunal set aside workman transfers and awarded reinstatement with back wages. The company plans to challenge these orders in the Punjab and Haryana High Court and does not foresee a material financial impact at this stage.

Execution
From 2014 onwards
11:54 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec Ltd has received a rectified Assessment Order for AY 2016-17 from the Income Tax Department. The order successfully nullifies the previous tax demand of approximately ₹10.23 Crore, determining the company's final tax liability as Nil. This rectification removes the potential financial liability and has a positive impact on the company's financials.

Value
₹10.23 Cr
11:48 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec Limited received a rectified Assessment Order from the Income Tax department for AY 2015-16. The rectification successfully nullifies a previous tax demand of approximately ₹45.71 Crore, resulting in Nil tax liability. This correction of errors regarding disallowances and losses provides a significant positive financial impact for the company.

Value
₹45.71 Cr